AW
OYST

ACG Wealth’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

ACG Wealth’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$59K Sell
10,500
-4,214
-29% -$26.4K 0.01% 243
2022
Q2 		$64K Buy
14,714
+502
+4% +$2.85K 0.01% 402
2022
Q1 		$165K Hold
14,212
– – 0.03% 264
2021
Q4 		$260K Buy
+14,212
New +$180K 0.04% 276

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACG Wealth's OYST Position: Q3 2022 in Review

ACG Wealth reduced its Oyster Point Pharma, Inc. Common Stock (OYST) stake by 29% in Q3 2022, selling an estimated $26.4K and leaving 10,500 shares worth $59K. The position accounts for 0.01% of the portfolio, ranked #243.

ACG Wealth first reported a position in OYST in Q4 2021 and has held it in 4 quarters since. The position peaked at $260K in Q4 2021. 60 funds tracked by Wall St. Rank hold OYST as of Q3 2022.

  • ACG Wealth held 10,500 shares of Oyster Point Pharma, Inc. Common Stock worth $59K as of Q3 2022.
  • ACG Wealth sold 4,214 Oyster Point Pharma, Inc. Common Stock shares in Q3 2022, an estimated $26.4K.
  • Oyster Point Pharma, Inc. Common Stock made up 0.01% of ACG Wealth's portfolio in Q3 2022, its #243 holding.
  • ACG Wealth first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2021 and has held it in 4 quarters since.
  • ACG Wealth's Oyster Point Pharma, Inc. Common Stock position peaked at $260K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.